Cargando…

HLA-Class II Artificial Antigen Presenting Cells in CD4(+) T Cell-Based Immunotherapy

CD4(+) T cells differentiate into various T helper subsets characterized by distinct cytokine secreting profiles that confer them effector functions adapted to a variety of infectious or endogenous threats. Regulatory CD4(+) T cells are another specialized subset that plays a fundamental role in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Couture, Alexandre, Garnier, Anthony, Docagne, Fabian, Boyer, Olivier, Vivien, Denis, Le-Mauff, Brigitte, Latouche, Jean-Baptiste, Toutirais, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6533590/ https://www.ncbi.nlm.nih.gov/pubmed/31156634 http://dx.doi.org/10.3389/fimmu.2019.01081

Ejemplares similares

Roles of the tissue-type plasminogen activator in immune response
por: Seillier, Célia, et al.
Publicado: (2022)

Tissue plasminogen activator worsens experimental autoimmune encephalomyelitis by complementary actions on lymphoid and myeloid cell responses
por: Hélie, Pauline, et al.
Publicado: (2021)

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring
por: Khoy, Kathy, et al.
Publicado: (2020)

Cancer vaccines: designing artificial synthetic long peptides to improve presentation of class I and class II T cell epitopes by dendritic cells
por: Rabu, Catherine, et al.
Publicado: (2019)

The ADAMTS13(1239–1253) peptide is a dominant HLA-DR1-restricted CD4(+) T-cell epitope
por: Gilardin, Laurent, et al.
Publicado: (2017)

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
por: de Vries, Natasja L., et al.
Publicado: (2023)

Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
por: Seillier, Célia, et al.
Publicado: (2022)

Identification of Claudin 6-specific HLA class I- and HLA class II-restricted T cell receptors for cellular immunotherapy in ovarian cancer
por: Matsuzaki, Junko, et al.
Publicado: (2022)

Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy
por: Hamieh, Mohamad, et al.
Publicado: (2021)

Astrocytes regulate the balance between plasminogen activation and plasmin clearance via cell-surface actin
por: Briens, Aurélien, et al.
Publicado: (2017)

HLA antigens in colorectal tumours--low expression of HLA class I antigens in mucinous colorectal carcinomas.
por: van den Ingh, H. F., et al.
Publicado: (1987)

Determining if T cell antigens are naturally processed and presented on HLA class I molecules
por: Friedman, Jay, et al.
Publicado: (2022)

Cell Surface B2m-Free Human Leukocyte Antigen (HLA) Monomers and Dimers: Are They Neo-HLA Class and Proto-HLA?
por: Ravindranath, Mepur H., et al.
Publicado: (2023)

ROLE OF HLA CLASS-I ANTIGENS IN DELUSIONAL DISORDER
por: Debnath, Monojit, et al.
Publicado: (2000)

Molecular Magnetic Resonance Imaging of Endothelial Activation in the Central Nervous System
por: Gauberti, Maxime, et al.
Publicado: (2018)

Presence of T cells directed against CD20-derived peptides in healthy individuals and lymphoma patients
por: Milcent, Benoit, et al.
Publicado: (2019)

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Potential Role of HLA Class I Antigens in the Glycolytic Metabolism and Motility of Melanoma Cells
por: Peppicelli, Silvia, et al.
Publicado: (2019)

Proteome Sampling by the HLA Class I Antigen Processing Pathway
por: Hoof, Ilka, et al.
Publicado: (2012)

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
por: Dillard, Pierre, et al.
Publicado: (2021)

The Association of HLA Class 1 and Class 2 Antigens with Multiple Myeloma in Iranian Patients
por: Sayad, Arezou, et al.
Publicado: (2014)

The association between chronic spontaneous urticaria and HLA class I and class II antigen
por: DOĞAN, Neslihan, et al.
Publicado: (2020)

Autoreactive T cell clones specific for class I and class II HLA antigens isolated from a human chimera
Publicado: (1988)

MELOE-1 Antigen Contains Multiple HLA Class II T Cell Epitopes Recognized by Th1 CD4+ T Cells from Melanoma Patients
por: Bobinet, Mathilde, et al.
Publicado: (2012)

Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy
por: Perica, Karlo, et al.
Publicado: (2014)

Melanoma and Human Leukocyte Antigen (HLA): Immunogenicity of 69 HLA Class I Alleles With 11 Antigens Expressed in Melanoma Tumors
por: Georgopoulos, Apostolos P, et al.
Publicado: (2023)

Direct evidence for binding of CD8 to HLA class I antigens
Publicado: (1989)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Human Leukocyte Antigen (HLA) class I and II datasets for sudanese
por: Dafalla, Ameer Mohamed, et al.
Publicado: (2019)

Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design
por: Doonan, Bently P, et al.
Publicado: (2015)

Expression of classical human leukocyte antigen class I antigens, HLA‐E and HLA‐G, is adversely prognostic in pancreatic cancer patients
por: Hiraoka, Nobuyoshi, et al.
Publicado: (2020)

Relevance of Polymorphic KIR and HLA Class I Genes in NK-Cell-Based Immunotherapies for Adult Leukemic Patients
por: Dubreuil, Léa, et al.
Publicado: (2021)

HLA Class I Knockout Converts Allogeneic Primary NK Cells Into Suitable Effectors for “Off-the-Shelf” Immunotherapy
por: Hoerster, Keven, et al.
Publicado: (2021)

Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes
por: Richardson, Sarah J., et al.
Publicado: (2016)

Epigenetic priming restores the HLA class-I antigen processing machinery expression in Merkel cell carcinoma
por: Ritter, Cathrin, et al.
Publicado: (2017)

HLA-A, B (Class I) and HLA-DR, DQ (Class II) Antigens in Turkish Patients with Recurrent Aphthous Ulceration and Behçet's Disease
por: Pekiner, Filiz Namdar, et al.
Publicado: (2013)

Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice
Publicado: (1994)

Cytotoxic T cell recognition of an endogenous class I HLA peptide presented by a class II HLA molecule
Publicado: (1990)

Expression of HLA Class I and HLA Class II by Tumor Cells in Chinese Classical Hodgkin Lymphoma Patients
por: Huang, Xin, et al.
Publicado: (2010)

Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
por: Eggermont, Loek J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_28c2612pssb3no0h7jg1id6skq